Pictet Asset Management Holding SA boosted its stake in Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 3.9% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 44,934 shares of the biotechnology company’s stock after buying an additional 1,669 shares during the quarter. Pictet Asset Management Holding SA owned approximately 0.06% of Axon Enterprise worth $26,705,000 as of its most recent SEC filing.
Several other large investors have also bought and sold shares of AXON. The Manufacturers Life Insurance Company increased its stake in Axon Enterprise by 0.6% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 43,643 shares of the biotechnology company’s stock valued at $17,440,000 after buying an additional 276 shares during the last quarter. Quantbot Technologies LP purchased a new stake in shares of Axon Enterprise during the third quarter valued at approximately $84,000. Townsquare Capital LLC bought a new stake in Axon Enterprise during the third quarter worth $261,000. Public Sector Pension Investment Board boosted its position in Axon Enterprise by 19.2% in the third quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock worth $1,240,000 after purchasing an additional 500 shares during the last quarter. Finally, Martingale Asset Management L P bought a new position in Axon Enterprise in the 3rd quarter valued at $252,000. 79.08% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently commented on the company. Needham & Company LLC reiterated a “buy” rating and set a $600.00 target price on shares of Axon Enterprise in a research note on Wednesday, February 26th. JMP Securities reaffirmed an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. Craig Hallum downgraded shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a research report on Monday, March 10th. TD Cowen initiated coverage on shares of Axon Enterprise in a report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price target on the stock. Finally, Robert W. Baird increased their price objective on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a report on Friday, December 6th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $604.67.
Axon Enterprise Stock Down 1.7 %
AXON stock opened at $525.95 on Tuesday. Axon Enterprise, Inc. has a twelve month low of $273.52 and a twelve month high of $715.99. The firm has a market capitalization of $40.30 billion, a PE ratio of 135.90, a PEG ratio of 5.17 and a beta of 1.12. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The stock has a 50-day simple moving average of $588.26 and a two-hundred day simple moving average of $551.61.
Insider Buying and Selling
In other news, Director Jeri Williams sold 307 shares of the business’s stock in a transaction on Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the transaction, the director now directly owns 1,627 shares in the company, valued at $899,275.44. The trade was a 15.87 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the sale, the director now owns 6,929 shares in the company, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. 6.10% of the stock is currently owned by insiders.
Axon Enterprise Company Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Stories
- Five stocks we like better than Axon Enterprise
- Stock Sentiment Analysis: How it Works
- 3 Buyable Stocks With Solid Bottoms Ready to Rebound
- How to Invest in Insurance Companies: A GuideĀ
- Advantage+ Shopping: Meta’s Fast Growing $20 Billion AI-Ads Star
- How to find penny stocks to invest and tradeĀ
- Robotaxi News: What Tesla and Lyft Headlines Mean for Shares
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.